PRPO logo

Precipio, Inc. Stock Price

NasdaqCM:PRPO Community·US$41.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

PRPO Share Price Performance

US$23.82
17.92 (303.73%)
US$23.82
17.92 (303.73%)
Price US$23.82

PRPO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
2 Rewards

Precipio, Inc. Key Details

US$22.8m

Revenue

US$12.6m

Cost of Revenue

US$10.2m

Gross Profit

US$11.5m

Other Expenses

-US$1.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.72
44.82%
-5.50%
0.6%
View Full Analysis

About PRPO

Founded
n/a
Employees
57
CEO
Ilan Danieli
WebsiteView website
www.precipiodx.com

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Recent PRPO News & Updates

Precipio, Inc. (NASDAQ:PRPO) Stock Rockets 28% But Many Are Still Ignoring The Company

Nov 19
Precipio, Inc. (NASDAQ:PRPO) Stock Rockets 28% But Many Are Still Ignoring The Company

Recent updates

No updates